Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation

Area of Science:

• Biomaterials Science
• Immunology
• Vascular Biology

Background:

• Dendrimers are synthetic hyperbranched macromolecules with precise structural control.
• Novel water-soluble dendrimer conjugates of glucosamine and glucosamine 6-sulfate were synthesized.

Purpose of the Study:

• To evaluate the immuno-modulatory and antiangiogenic properties of dendrimer conjugates.
• To assess the efficacy of these dendrimers in preventing scar tissue formation after glaucoma surgery.

Main Methods:

• Dendrimer glucosamine inhibited Toll-like receptor 4-mediated inflammatory responses in human dendritic cells and macrophages.
• Dendrimer glucosamine 6-sulfate blocked fibroblast growth factor-2 induced endothelial cell proliferation and angiogenesis.
• Synergistic effects were tested in a rabbit model of glaucoma filtration surgery.

Main Results:

• Dendrimer glucosamine modulated pro-inflammatory cytokine and chemokine synthesis while upregulating costimulatory molecules.
• Dendrimer glucosamine 6-sulfate demonstrated potent antiangiogenic activity.
• Combined use of dendrimer glucosamine and dendrimer glucosamine 6-sulfate increased glaucoma surgery success rate from 30% to 80% (P = 0.029).

Conclusions:

• Synthetically engineered dendrimers can be tailored for specific immuno-modulatory and antiangiogenic functions.
• These dendrimers show synergistic potential in preventing scar tissue formation.
• Dendrimer-based therapeutics offer a promising approach for enhancing surgical outcomes.